Literature DB >> 312169

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.

N Thatcher, R Swindell, D Crowther.   

Abstract

C. parvum and BCG produced significant changes in NK, K and T cell lymphocytotoxicity using a Chang liver target cell. A consistent temporal pattern over 28 days of early depression, recovery, overshoot and then decline was described. This was particularly marked for C. parvum and 'K' cell activity. Skin test reactivity to recall antigens at 28 days was not appreciably different from the pre-immunization reactivity. The importance of using lymphocyte concentration-cytotoxicity titration curves and the linearization of such curves is discussed. An immunotherapy schedule with 3 weekly immunization intervals is proposed as the optimum schedule in patients receiving C. parvum at a dose of 2.0 mg/m2 i.v.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312169      PMCID: PMC1537637     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  D L Nelson; B M Bundy; H E Pitchon; R M Blaese; W Strober
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  Changes in cellular immunity following nephrectomy for localized and metastatic hypernephroma.

Authors:  N Thatcher; R J Barnard; N Gasiunas; D Crowther
Journal:  Eur J Cancer       Date:  1977-09       Impact factor: 9.162

3.  Surface characteristics of the human K (killer) lymphocyte.

Authors:  O Eremin; D Kraft; R R Coombs; D Franks; J Ashby; D Plumb
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

4.  Antibody in the induction and inhibition of lymphocyte cytotoxicity.

Authors:  I C MacLennan
Journal:  Transplant Rev       Date:  1972

5.  Cytotoxic lymphocytes from rats depleted of thymus processed cells.

Authors:  B Harding; D J Pudifin; F Gotch; I C MacLennan
Journal:  Nat New Biol       Date:  1971-07-21

6.  The cytotoxic effector potential of some common non-lymphoid tumors and cultured cell lines with phytohemagglutinin and heterologous anti-erythrocyte antisera.

Authors:  A V Muchmore; D L Nelson; R M Blaese
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

7.  Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

8.  Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin.

Authors:  D A Horwitz; P I Lobo
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.

Authors:  G W Hunninghake; B F Haynes; J E Parrillo; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

10.  Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.

Authors:  N Thatcher; M K Palmer; N Gasiunas; D Crowther
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

View more
  5 in total

1.  Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study.

Authors:  E la Cour Petersen; P Hokland; J Ellegaard
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

3.  Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.

Authors:  H F Pross; M G Baines; P Rubin; P Shragge; M S Patterson
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

4.  Decreased monocyte antibody-dependent cell-mediated toxicity in stage I-II malignant melanoma. Augmentation by subcutaneous Corynebacterium parvum.

Authors:  J L Murray; E T Lee
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 5.  Natural killer cells in human solid tumors.

Authors:  M Introna; A Mantovani
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.